Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-19

FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fluphenazine Decanoate by Hikma Pharmaceuticals USA Inc. for continued marketing of this long-acting injectable anti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

SUPPL AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)